Neurodynamic Moblization Versus Mulligan on Pain and Functional Abilities in Patients With Chroni… (NCT07050108) | Clinical Trial Compass
CompletedNot Applicable
Neurodynamic Moblization Versus Mulligan on Pain and Functional Abilities in Patients With Chronic Discogenic Sciatica
Egypt66 participantsStarted 2025-08-10
Plain-language summary
The purpose of the present study to compare between the effect of neurodynamic moblizaton and Mulligan SNAG's moblization on patients with chronic unilateral discogenic sciatica.
Who can participate
Age range35 Years – 50 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* All the patients diagnosed as lumbar radiculopathy (L5-S1) for at least six months. Diagnosis was confirmed by physical, neurological examination (motor assessment, sensory assessment, reflexes) and radiological assessment (CT or MRI).
* All patients has second grade of disc bulge which will detect from T2 axial view of MRI according to Fardon and Milette
* All patients has unilateral radiculopathy and pain in the distribution of scaitic nerve.
* The age of the patients will range from 35 to 50years . Their body mass index will range between( 22-25)
Exclusion Criteria:
* Bilateral and multilevel disc prolapse or bilateral radtadiating pain
* acute pain (pain less than three months).
* Presence of active infection in lumbar spine.
* Any other spinal deformities.
* Postoperative cases.
* Cauda equine lesion.
* Neoplasmic.
* Spinal stenosis.
* Mechanical low back pain.
* Failed back syndrome.